NMN (nicotinamide mononucleotide)
β-Nicotinamide Mononucleotide (NMN) · also known as NMN, β-NMN, NAD+ precursor
NMN is a direct precursor of NAD+. Human randomized trials have confirmed that oral NMN raises blood NAD+ levels. Whether it drives the sirtuin and PGC-1α pathways in target tissues has not been confirmed in humans, and data on long-term benefit are also very limited.
Clinical uses and human evidence
Blood sugar and insulin resistance
Studies (2)
- Yoshino 2021 · Science · RCT · n=25 — Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
- Yang 2026 · Nutrients · Meta-analysis — Safety and Metabolism-Related Outcomes of Oral Nicotinamide Mononucleotide Supplementation in Adults: A Systematic Review and Meta-Analysis
Endurance performance
Fatigue and energy
Mechanisms of action
Replenishing the NAD+ pool via the salvage pathway
NMN is converted directly to NAD+ by NMNAT1-3 and is a key precursor for NAD+ synthesis. Human randomized trials showed that blood NAD+ rises after oral dosing, but responses differ across tissues and cell compartments, and results in skeletal muscle are inconsistent.
Skeletal muscle GLUT4 translocation and insulin sensitivity
One randomized controlled trial (25 postmenopausal women with overweight and prediabetes): after 250 mg daily for 10 weeks, muscle insulin sensitivity measured by clamp improved and muscle AKT phosphorylation increased. This is the only study so far, and the finding has yet to be tested in other populations.
Sirtuin-dependent protein deacetylase activation
NAD+ is an essential co-substrate for sirtuin deacetylation reactions, so higher NAD+ is in theory beneficial for sirtuin activity. However, supplying a precursor does not necessarily raise enzyme activity. A mouse study observed SIRT3-dependent protein deacetylation, but direct evidence after oral NMN in humans is still lacking.
PGC-1α-driven mitochondrial biogenesis and proliferation
NMN could in theory activate PGC-1α through SIRT1-mediated deacetylation. In the heart muscle of SIRT3-deficient mice, NMN increased proteins such as PGC-1α and TFAM. However, a rise in blood NAD+ in humans does not show that mitochondrial numbers increase, so mitochondrial biogenesis in humans has not been confirmed.